Tentative Settlement Reached In Consumer’s Deceptive ChapStick Label Class Suit
SAN FRANCISCO — A California woman who accuses GlaxoSmithKline Consumer Healthcare Holdings (US) LLC (GSK) and Pfizer Inc. of deceptively labeling of certain ChapStick products in violation of California law, including...To view the full article, register now.
Already a subscriber? Click here to view full article